Healthcare & Life Sciences
Reapplix
Finlandreapplix.com
Reapplix is a Healthcare & Life Sciences startup based in Finland, most recent round Series B, 3 tracked investors.
activeseries-b
series-b
Stage
3
Investors
About Reapplix
Reapplix is a startup based in Finland. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
Reapplix develops personalized wound healing technology called the 3C Patch®, an autologous blood-derived patch that accelerates healing of hard-to-heal diabetic foot ulcers.
Explore Reapplix's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.